A Small Step Toward Improving Systemic Treatment for Metastatic Bladder Cancer--At What Cost?

Eur Urol. 2016 Apr;69(4):642-644. doi: 10.1016/j.eururo.2015.08.039. Epub 2015 Sep 4.

Authors

Tracy L Rose¹, Matthew I Milowsky²

Affiliations

¹ Department of Medicine, Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, NC, USA.
² Department of Medicine, Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, NC, USA. Electronic address: matt_milowsky@med.unc.edu.

PMID: 26346677
DOI: 10.1016/j.eururo.2015.08.039

No abstract available

Publication types

Editorial
Comment

MeSH terms

Costs and Cost Analysis*
Humans
Urinary Bladder Neoplasms*